Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Evaluation of Albuminuria in HIV Positive Patients

NCT00524992 is registered in ClinicalTrials.gov with National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) as lead sponsor.

NCT NCT00524992
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00524992 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Evaluation of Albuminuria in HIV Positive Patients
Lead sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Phase
Observational
Overall status
Completed
Start date
August 29, 2007
Completion date
December 24, 2014
Enrollment
252 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

albuminuria, hiv-associated collapsing glomerulopathy, hiv-associated focal segmental glomerulosclerosis, proteinuria, renal tubular toxicity